tirzepatide breastfeeding data and Breastfeeding: What Moms Need to Know tirzepatide breastfeeding data Ozempic® or
Description
Notably, 31% of patients on GLP-1 RAs became completely headache-free at 6 months, versus only 8% of those on usual care (this difference did not remain significant after adjusting for weight loss)
However, only three of the 12 articles included mainly studied on people in the Asia Pacific region, and further data on the efficacy and safety of tirzepatide in the broader Asian patient population are needed
Craft 2009)
These effects can sometimes be mitigated with proper hydration, electrolyte supplementation, and gentle exercise
